Looking To Enter High Potential Mkts: Lupin
  • Prabha Hedge
  • Jan 13 2014

January 13: Lupin has been in the news off late, after it received the U.S. FDA approval for hypertension drug Twynsta, adding yet another product to its expanding portfolio. Mini Menon caught up with Nilesh Gupta, MD, Lupin to find out what the road ahead is looking like for the company and how it plans to expand its global reach.